Forum to aid Fibromyalgia sufferers
Kettering University has teamed up with physicians at McLaren Regional Medical Center of Flint to test a new treatment for sufferers of Fibromyalgia and chronic pain.
Kettering University has teamed up with physicians at McLaren Regional Medical Center of Flint to test a new treatment for sufferers of Fibromyalgia and chronic pain. The Flint clinical trial will be the first of its kind in Michigan and only the fourth such trial in the country. Other clinical trials were conducted in Chicago, Washington, D.C. and Buffalo. Preliminary results of the treatment are encouraging.
A free public forum about the new treatment will be in McKinnon Theatre at Kettering University Monday, Jan. 21, at 7 p.m. The forum will feature:
- Dr. David Simons of DeKalb Medical Center in Atlanta,
- Dr. Mary Lee Esty, president of the Neurotherapy Center of Washington, D.C., and
- Dr. Jeff Hargrove, assistant professor of Mechanical Engineering at Kettering and adjunct assistant professor of Medicine at Michigan State University.
Symptoms of Fibromyalgia include full body diffuse pain, cognitive dysfunction and chronic fatigue. It affects women nine times more frequently than men. An estimated 4 percent of the general population is affected by Fibromyalgia, representing an estimated $2,274 per patient for health care annually. Total health care costs nationwide for Fibromyalgia sufferers is between $12 and $15 billion per year.
Causes of Fibromyalgia are generally unknown, although several pathological factors have been identified in research. Current treatments provide only a degree of relief and are generally ineffective over the long term. The new treatment draws on many medical disciplines and can offer successful management of chronic pain.
For more information about the public forum, call Kettering's Department of Mechanical Engineering at (810) 762-9791.